SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000819050-19-000010
Filing Date
2019-09-10
Accepted
2019-09-10 16:22:38
Documents
8
Effectiveness Date
2019-09-10

Document Format Files

Seq Description Document Type Size
1 S-8 s8.htm S-8 101109
2 EXHIBIT 4.1 ex41.htm EX-4.1 6079
3 EXHIBIT 5.1 ex51.htm EX-5.1 9146
4 EXHIBIT 23.1 ex231.htm EX-23.1 5782
5 EXHIBIT 99.2 ex992.htm EX-99.2 110927
6 EXHIBIT 99.3 ex993.htm EX-99.3 34266
7 mbimage.jpg GRAPHIC 4057
8 stockcertificate.gif GRAPHIC 21049
  Complete submission text file 0000819050-19-000010.txt   303048
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233698 | Film No.: 191085591
SIC: 2836 Biological Products, (No Diagnostic Substances)